Inovie Group, a French laboratory chain backed by Ardian SAS, is considering a potential share sale for more than 3.0 billion euros ($3.2 billion). This is reported by foreign media.
Ardian has engaged consultants to assess the real value of Inovie and determine the terms of the proposed sale in the second half of 2024. Ardian acquired a minority stake in Inovie in 2020.
Investor interest in laboratory services increased during the Covid pandemic, but then demand declined. In 2022, Ardian considered the possibility of selling a controlling stake in Cinven..
Inovie is a major company in the field of medical diagnostics. The company provides a wide range of services, including genomic and molecular biology, anatomopathology, diagnosis and treatment of infertility, veterinary biological analysis and specialized analyses. The customer base includes 1,500 medical institutions. The headquarters is located in Montpellier (France) with 650 laboratory sites.
Ardian is a French private equity asset management company. The company invests in private market funds, industrial companies, infrastructure, office real estate, and provides non-bank financial and lending services. The headquarters is located in Paris (France).
More news is on the Telegram channel "Mergers and Acquisitions. AK&M».
